{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:18:38Z","timestamp":1791253118361,"version":"4.1.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00824","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T05:03:55Z","timestamp":1566882235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications"],"prefix":"10.3389","volume":"9","author":[{"given":"Tarik","family":"M\u00f6r\u00f6y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Khandanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","article-title":"Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial","volume":"35","author":"Platzbecker","year":"2017","journal-title":"J Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/leu.2012.49","article-title":"Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding","volume":"26","author":"Ptasinska","year":"2012","journal-title":"Leukemia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1182\/blood-2016-11-750976","article-title":"A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program","volume":"130","author":"Lin","year":"2017","journal-title":"Blood."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.05.005","article-title":"RUNX1-ETO and RUNX1-EVI1 differentially reprogram the chromatin landscape in t(8;21) and t(3;21) AML","volume":"19","author":"Loke","year":"2017","journal-title":"Cell Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/jcb.10548","article-title":"Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism","volume":"89","author":"McGhee","year":"2003","journal-title":"J Cell Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1182\/blood-2009-10-248047","article-title":"Dimer-tetramer transition controls RUNX1\/ETO leukemogenic activity","volume":"116","author":"Wichmann","year":"2010","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1182\/blood-2015-07-604512","article-title":"Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia","volume":"127","author":"Wouters","year":"2016","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1038\/sj.onc.1205318","article-title":"Hematopoietic cytokines, transcription factors and lineage commitment","volume":"21","author":"Zhu","year":"2002","journal-title":"Oncogene."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/embj.201386825","article-title":"Key regulators control distinct transcriptional programmes in blood progenitor and mast cells","volume":"33","author":"Calero-Nieto","year":"2014","journal-title":"EMBO J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","article-title":"Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome","volume":"113","author":"Wouters","year":"2009","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng1361","article-title":"Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1","volume":"36","author":"Rosenbauer","year":"2004","journal-title":"Nat Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/leu.2016.11","article-title":"GFI1 as a novel prognostic and therapeutic factor for AML\/MDS","volume":"30","author":"H\u00f6nes","year":"2016","journal-title":"Leukemia."},{"key":"B18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri2024","article-title":"Transcription factors in myeloid development: balancing differentiation with transformation","volume":"7","author":"Rosenbauer","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.exphem.2015.05.018","article-title":"MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia","volume":"43","author":"Gentner","year":"2015","journal-title":"Exp Hematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/leu.2010.195","article-title":"Gfi1 and Gfi1b: key regulators of hematopoiesis","volume":"24","author":"van der Meer","year":"2010","journal-title":"Leukemia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MOH.0b013e32833a06f8","article-title":"Gfi1-cells and circuits: unraveling transcriptional networks of development and disease","volume":"17","author":"Phelan","year":"2010","journal-title":"Curr Opin Hematol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1182\/blood-2015-06-655043","article-title":"From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation","volume":"126","author":"Moroy","year":"2015","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/ni.2743","article-title":"Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1","volume":"14","author":"Spooner","year":"2013","journal-title":"Nat Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ncb3276","article-title":"GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1","volume":"18","author":"Thambyrajah","year":"2016","journal-title":"Nat Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1182\/blood-2011-10-386094","article-title":"GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment","volume":"120","author":"Lancrin","year":"2012","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1038\/sj.emboj.7600419","article-title":"Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells","volume":"23","author":"Zeng","year":"2004","journal-title":"EMBO J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nature02994","article-title":"Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells","volume":"431","author":"Hock","year":"2004","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"40906","DOI":"10.1074\/jbc.M400808200","article-title":"Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development","volume":"279","author":"Yucel","year":"2004","journal-title":"J Biol Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng831","article-title":"Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1","volume":"30","author":"Karsunky","year":"2002","journal-title":"Nat Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.molcel.2007.06.039","article-title":"Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1","volume":"27","author":"Saleque","year":"2007","journal-title":"Mol Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"32056","DOI":"10.1074\/jbc.M802320200","article-title":"Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor","volume":"283","author":"Montoya-Durango","year":"2008","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.02.005.","article-title":"Aberrations in DNA repair pathways in cancer and therapeutic significances","author":"Motegi","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41467-018-03817-5","article-title":"GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1","volume":"9","author":"Vadnais","year":"2018","journal-title":"Nat Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/jcp.25053","article-title":"Error-prone repair of DNA double-strand breaks","volume":"231","author":"Rodgers","year":"2016","journal-title":"J Cell Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1128\/MCB.23.7.2556-2563.2003","article-title":"p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice","volume":"23","author":"Ward","year":"2003","journal-title":"Mol Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.dnarep.2004.03.023","article-title":"NBS1 and its functional role in the DNA damage response","volume":"3","author":"Kobayashi","year":"2004","journal-title":"DNA Repair."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine methylation: the coming of age","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.molcel.2018.06.033","article-title":"20 years of Mre11 biology: no end in sight","volume":"71","author":"Paull","year":"2018","journal-title":"Mol Cell."},{"key":"B39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature06092","article-title":"p53 is regulated by the lysine demethylase LSD1","volume":"449","author":"Huang","year":"2007","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ccr.2013.01.011","article-title":"Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia","volume":"23","author":"Khandanpour","year":"2013","journal-title":"Cancer Cell."},{"key":"B41","doi-asserted-by":"publisher","first-page":"374","DOI":"10.18632\/oncotarget.933","article-title":"Growth factor independence 1 (Gfi1) as a regulator of p53 activity and a new therapeutical target for ALL","volume":"4","author":"Khandanpour","year":"2013","journal-title":"Oncotarget."},{"key":"B42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41375-018-0166-1","article-title":"Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice","volume":"33","author":"Fraszczak","year":"2019","journal-title":"Leukemia."},{"key":"B43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.biocel.2004.08.011","article-title":"The zinc finger transcription factor Growth factor independence 1 (Gfi1)","volume":"37","author":"Moroy","year":"2005","journal-title":"Int J Biochem Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.moh.0000190111.85284.8f","article-title":"Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells","volume":"13","author":"Hock","year":"2006","journal-title":"Curr Opin Hematol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood-2009-08-239822","article-title":"A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia","volume":"115","author":"Khandanpour","year":"2010","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.3324\/haematol.2017.180844","article-title":"GFI1 is required for RUNX1\/ETO positive acute myeloid leukemia","volume":"103","author":"Marneth","year":"2018","journal-title":"Haematologica."},{"key":"B47","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.exphem.2016.04.001","article-title":"GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome","volume":"44","author":"Botezatu","year":"2016","journal-title":"Exp Hematol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1182\/blood-2011-02-334722","article-title":"The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice","volume":"120","author":"Khandanpour","year":"2012","journal-title":"Blood."},{"key":"B49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.exphem.2016.05.004","article-title":"Epigenetic therapy as a novel approach for GFI136N-associated murine\/human AML","volume":"44","author":"Botezatu","year":"2016","journal-title":"Exp Hematol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1182\/blood-2010-04-280305","article-title":"Evidence that growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells","volume":"116","author":"Khandanpour","year":"2010","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1182\/blood-2009-09-241752","article-title":"Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-megakaryocytic progenitor stage","volume":"115","author":"Randrianarison-Huetz","year":"2010","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1182\/blood-2009-06-230094","article-title":"High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription","volume":"115","author":"Laurent","year":"2010","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1182\/blood-2003-11-4068","article-title":"Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells","volume":"105","author":"Gar\u00e7on","year":"2005","journal-title":"Blood."},{"key":"B54","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1084\/jem.20131065","article-title":"Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation","volume":"211","author":"Foudi","year":"2014","journal-title":"J Exp Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1101\/gad.959102","article-title":"The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages","volume":"16","author":"Saleque","year":"2002","journal-title":"Genes Dev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e96636","DOI":"10.1371\/journal.pone.0096636","article-title":"Growth factor independence 1b (gfi1b) is important for the maturation of erythroid cells and the regulation of embryonic globin expression","volume":"9","author":"Vassen","year":"2014","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1182\/blood-2002-01-0182","article-title":"Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis","volume":"100","author":"Osawa","year":"2002","journal-title":"Blood."},{"key":"B58","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3324\/haematol.2016.150375","article-title":"Gfi1b controls integrin signaling-dependent cytoskeleton dynamics and organization in megakaryocytes","volume":"102","author":"Beauchemin","year":"2017","journal-title":"Haematologica."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.4049\/jimmunol.170.5.2356","article-title":"Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment","volume":"170","author":"Doan","year":"2003","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1084\/jem.20110645","article-title":"Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1","volume":"209","author":"Schulz","year":"2012","journal-title":"J Exp Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1182\/blood-2006-06-030031","article-title":"Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1","volume":"109","author":"Vassen","year":"2007","journal-title":"Blood."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1038\/sj.emboj.7601124","article-title":"Gfi1b alters histone methylation at target gene promoters and sites of gamma-satellite containing heterochromatin","volume":"25","author":"Vassen","year":"2006","journal-title":"EMBO J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1128\/MCB.25.23.10338-10351.2005","article-title":"Gfi1 coordinates epigenetic repression of p21Cip\/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1","volume":"25","author":"Duan","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1242\/jcs.177519","article-title":"Reciprocal regulation of alternative lineages by Rgs18 and its transcriptional repressor Gfi1b","volume":"129","author":"Sengupta","year":"2016","journal-title":"J Cell Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41467-019-09273-z","article-title":"Gfi1b regulates the level of Wnt\/\u03b2-catenin signaling in hematopoietic stem cells and megakaryocytes","volume":"10","author":"Shooshtarizadeh","year":"2019","journal-title":"Nat Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa1308130","article-title":"A dominant-negative GFI1B mutation in the gray platelet syndrome","volume":"370","author":"Monteferrario","year":"2014","journal-title":"N Engl J Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1128\/MCB.18.5.2462","article-title":"The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation","volume":"18","author":"Tong","year":"1998","journal-title":"Mol Cell Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3324\/haematol.2017.167288","article-title":"Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndrome","volume":"103","author":"Thivakaran","year":"2018","journal-title":"Haematologica."},{"key":"B69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","article-title":"Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling","volume":"94","author":"Verhaak","year":"2009","journal-title":"Haematologica."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ydbio.2016.02.002","article-title":"A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network","volume":"411","author":"Anguita","year":"2016","journal-title":"Dev Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1868-7083-5-12","article-title":"Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents","volume":"5","author":"Fredly","year":"2013","journal-title":"Clin Epigenetics."},{"key":"B73","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.biopha.2018.02.039","article-title":"Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1","volume":"100","author":"Cheng","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"15720","DOI":"10.1038\/s41598-017-15866-9","article-title":"Enforced GFI1 expression impedes human and murine leukemic cell growth","volume":"7","author":"H\u00f6nes","year":"2017","journal-title":"Sci Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"11148","DOI":"10.1038\/s41598-017-11718-8","article-title":"Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature","volume":"7","author":"Volpe","year":"2017","journal-title":"Sci Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.molcel.2015.01.010","article-title":"A specific LSD1\/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation","volume":"57","author":"Laurent","year":"2015","journal-title":"Mol Cell."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41375-018-0375-7","article-title":"LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML","volume":"33","author":"Barth","year":"2019","journal-title":"Leukemia."},{"key":"B78","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41467-018-08269-5","article-title":"Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1481813","DOI":"10.1080\/23723556.2018.1481813","article-title":"LSD1 inhibitors disrupt the GFI1 transcription repressor complex","volume":"5","author":"Maiques-Diaz","year":"2018","journal-title":"Mol Cell Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/leu.2014.119","article-title":"Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells","volume":"28","author":"Fiskus","year":"2014","journal-title":"Leukemia."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/leu.2017.59","article-title":"A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers","volume":"31","author":"Sugino","year":"2017","journal-title":"Leukemia."},{"key":"B82","doi-asserted-by":"publisher","first-page":"E324","DOI":"10.3390\/cancers11030324","article-title":"Expanding the role of the histone lysine-specific demethylase LSD1 in cancer","volume":"11","author":"Majello","year":"2019","journal-title":"Cancers."},{"key":"B83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41589-019-0263-0","article-title":"CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML","volume":"15","author":"Vinyard","year":"2019","journal-title":"Nat Chem Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1101\/gad.262170.115","article-title":"Histone modifications predispose genome regions to breakage and translocation","volume":"29","author":"Burman","year":"2015","journal-title":"Genes Dev."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.03.005","article-title":"Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition","volume":"35","author":"Ferguson","year":"2015","journal-title":"Semin Cancer Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cell.2011.07.048","article-title":"Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes","volume":"147","author":"Klein","year":"2011","journal-title":"Cell."},{"key":"B87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cancers10010013","article-title":"Translocation breakpoints preferentially occur in euchromatin and acrocentric chromosomes","volume":"10","author":"Lin","year":"2018","journal-title":"Cancers."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T05:03:57Z","timestamp":1566882237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":87,"alternative-id":["10.3389\/fonc.2019.00824"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00824","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"article-number":"824"}}